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CORRESPONDENCEIs It Right ASA Scoring to be Used in Identiﬁcation of
Nonoperated Patients?
Although with limited number of patients, we appreciate
the authors for their study investigating the rates of
rupture and mortality that was developed in inoperable
abdominal aortic aneurysm.1 First we wanted to state
a technical mistake in the paper that drew our attention.
Despite the total number of patients included in the study
is 72, there are 71 patients in Figure 1. Since the number of
patients is small, we believe that this missing patient
should be included in the relevant group. However, our
actual review about the article is that the authors grouped
the patients according to the ASA and gave the number of
deaths and ruptures of these groups. Several studies re-
ported ASA scoring to be effective both on anesthesic and
surgical outcome.2,3 However, we believe that this param-
eter which is used in preoperative risk scoring should not
be used to identify nonoperated patients. Already looking
to Figure 1, survival rate in the ASA 4 group (48%) is seen
to be unexpectedly higher than ASA 2 group (38%). This
shows us that evaluation of the risk for rupture and
mortality between ASA groups is meaningless. We would
want to say that we wonder about the views of the authors
on our this critics.REFERENCES
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Re. ‘Is It Right ASA Scoring to be Used in Identiﬁcation of
Nonoperated Patients?’
Sir,
We thank Dr Gokalp and colleagues for their interest in our
paper on palliation of aortic aneurysms. Our study con-
tained 72 patients however, we were unable to determine
cause of death in one individual as they died abroad and
therefore we were unable to include them in the analysis of
cause of death.
ASA grade has been used in many studies to stratify
surgical risk.1,2 ASA grade is only one factor considered in
our unit when deciding suitability for aneurysm repair and,
unsurprisingly, the majority of patients included in this
study were ASA-3 (41) or ASA-4 (22). Of the small number
of ASA-2 patients (8), ﬁve declined operative intervention,
some of whom would have been suitable candidates for
aneurysm repair, so possibly changing subsequent outcome
(25% of this cohort died of rupture). We therefore feel that
as the majority of this group in our study self-selected
themselves out of surgery, they cannot be seen as repre-
sentative in terms of outcome.
Following assessment by a Consultant Vascular Surgeon,
patients in our unit are subjected to CPEX testing and
Consultant Anaesthetist review. This was not consistent in
the early days of our CPEX programme but is standard
practice now. All these factors are combined to give
a deﬁnitive judgement on suitability for intervention at this
point in time. This can be revisited in the future if aneurysm
expansion shifts risk-beneﬁt ratio in favour of surgery.
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Re. ‘An Online Patient Completed Aberdeen Varicose Vein
Questionnaire Can Help to Guide Primary Care Referrals’
We read with interest the study by Ward et al. concerning
an online completion of the disease speciﬁc quality of life
Aberdeen Varicose Vein questionnaire (AVVQ).1 The study is
thought provoking however surely the use of a non-vali-
dated tool renders such extrapolations moot. Without the
original full questionnaire no comparisons can be drawn.
Multiple other questionnaires exist which do not require
a drawing such as Chronic Lower Limb Venous Insufﬁciency
Questionnaire (CIVIQ)2 or Speciﬁc Quality of Life and
Outcome Response e Vascular (SQOR-V).3 Additionally,
construction of an online drawing tool is now well within
our technological grasp.
CEAP grade 4e6 showed a high prevalence in this study
(42%) with a consequently high average VCSS (mean 18.6).
However, this is not reﬂected in the AVVQ scores (mean
21.8). Additionally the correlation for CEAP and AVVQ
scores is not documented e is this clinically as well as
statistically signiﬁcant? Previous work in our unit has shown
good correlation between the AVVQ and CEAP, and AVVQ
and generic quality of life measures, but poor correlations
between VCSS and AVVQ; VCSS and (SQOR-V); and AVVQ
and SQOR-V.4 Current work being undertaken in our unit
has shown excellent correlation between CIVIQ and AVVQ.5
Most concerningly, however, is the number of patients with
C2S disease (symptomatic disease) for whom the authors feel it
is appropriate to deny intervention (47% of their cohort).This is
in disagreement with extensive work that details the progres-
sion of venous disease6 and the cost of treating only compli-
cated disease,7 not to mention the signiﬁcant quality of life
impairments seen with symptomatic disease8 which improve
with treatment.9 Finally, it has previously been shown that
treating uncomplicated venous disease leads to a greater
improvement than leaving thedisease toprogress topermanent
damage10 e the very patients excluded have the most to gain.
Yours Sincerely,
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Response to ‘Re. An Online Patient Completed Aberdeen
Varicose Vein Questionnaire Can Help to Guide Primary
Care Referrals’
Messers Lane, Franklin and Davies have provided additional
points for discussion which should be considered if the
study is to be repeated. The topic of limiting healthcare is
controversial and we are not surprised that our article
attracted their response.
We agree that the use of the on-line AVVQ tool will result
in patients with C2 disease being denied access to state
funded healthcare with the potential outcomes described.
It was not our decision to limit access to healthcare but that
of the commissioners who set a budget that they could
afford. Whether we agree with the concept of limiting the
treatment of venous disease to certain groups was not
